Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recessively inherited coagulation disorders.

Pier Mannuccio Mannucci1, Stefano Duga, Flora Peyvandi

  • 1Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Dermatology/IRCCS, Maggiore Hospital, University of Milan, Via Pace 9, 20122 Milan, Italy. pmmannucci@libero.it

Blood
|May 13, 2004
PubMed
Summary

Rare autosomal recessive bleeding disorders, excluding hemophilia A and B, affect 1 in 500,000 to 2 million people. This review details their genetics, symptoms, and management based on over 1000 patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19.

Internal and emergency medicine·2024
Same author

D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation.

Blood advances·2024
Same author

Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging.

Haemophilia : the official journal of the World Federation of Hemophilia·2024
Same author

Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2024
Same author

ISTH's new strategic plan 2024-2028: A transformative journey toward shaping the future of thrombosis and hemostasis.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Gender equity in hemophilia: need for healthcare, familial, and societal advocacy.

Frontiers in medicine·2024

Area of Science:

  • Hematology
  • Genetics
  • Rare Diseases

Background:

  • Autosomal recessive coagulation factor deficiencies (excluding FVIII/FIX) are rare, with varied prevalence.
  • Their clinical presentation, molecular basis, and management are less defined than hemophilia A/B.
  • Consanguinity in certain populations increases the incidence of recessive genetic disorders.

Purpose of the Study:

  • To review the genetic basis of rare, recessively inherited coagulation disorders.
  • To outline prevalent clinical manifestations and management strategies.
  • To identify steps for improving care for affected patients.

Main Methods:

  • Investigated over 1000 patients with recessively inherited coagulation disorders.
  • Data sourced from Italy and Iran, a region with high consanguinity rates.

Related Experiment Videos

  • Literature review and clinical experience synthesis.

    • Main Results:

    • Detailed review of genetic underpinnings of these rare bleeding disorders.
    • Description of common clinical symptoms and bleeding patterns.
    • Established management protocols and treatment approaches.

    Conclusions:

    • Rare coagulation factor deficiencies require specific diagnostic and management approaches.
    • Improved understanding of genetics and clinical features is crucial.
    • Targeted interventions are needed to enhance patient care and outcomes.